Mariam Maglakelidze

Mariam Maglakelidze

Auto-generated profile, based on publicly available information

Mariam Maglakelidze

Georgian Respiratory Association, Tbilisi, Georgia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in The Lancet Planetary Health
Verified
Journal Article
Open access
NPNicole de Paula
Nicole de Paula
LJLaura Jung
Laura Jung
KMKathleen Mar
Kathleen Mar
KBKathryn Bowen
Kathryn Bowen
MMMariam Maglakelidze
Mariam Maglakelidze
SGSophie Gepp
Sophie Gepp

1 September 2024 in Global Health Research
Verified
Journal Article
Open access
ADAndrew P Dickens
Andrew P Dickens
NGNicola Gale
Nicola Gale
PAPeymane Adab
Peymane Adab
KCK.K. Cheng
K.K. Cheng
CCChunhua Chi
Chunhua Chi
RJRachel Jordan
Rachel Jordan
Background: Health research should be locally prioritised by key stakeholders to ensure the best use of available resources, maximum likelihood of research leading to uptake into policy and practice and relevance to the needs of the potential beneficiaries. Established approaches are complex and time-consuming, therefore not feasible in settings where prioritisation is uncommon and time is limited. Objectives: We developed and applied a simple, rapid research prioritisation approach to elicit the views of stakeholders. Setting and participants: This was a collaboration between a multidisciplinary group of United Kingdom academics, the International Primary Care Respiratory Group and primary care respiratory researchers from four low- and middle-income countries: Brazil, China, Georgia and North Macedonia. We identified 10 topics for research prioritisation through workshops involving 26 topic, methods and local context experts, and considering the programme remit, to develop, adapt and evaluate culturally appropriate community and behavioural approaches for the prevention, early identification and management of chronic obstructive pulmonary disease in primary care. Design and methods: In each setting, local research teams convened stakeholder groups of patients, clinicians, managers/policymakers and researchers. Each group briefly discussed the 10 potential research study topics. Discussions were facilitated using short vignettes for each topic, and participants were encouraged to consider importance, feasibility and equity. Individual participants rated each study on a three-point traffic light scale, then ranked them following a facilitated discussion on what drove the ratings. The research team rated then ranked each study considering three further criteria (international novelty, potential for future funding and capacity building on a five-point scale). Within each group, ranks were summed to create a final rank order which guided our research programme and provided insight for future projects. Results: In each country, four to eight members attended each stakeholder group. The engagement process was completed in less than 4 hours and feedback was very positive, especially from patients who valued the opportunity to contribute to research decision-making about their own condition. Ranking varied to some extent between groups and settings, but there was consistency around topics that were prioritised among the top five in all groups (identifying efficient chronic obstructive pulmonary disease screening test strategies, evaluations of lung age to aid smoking cessation, feasibility of locally adapted pulmonary rehabilitation, clinical education for primary care staff) and study topics that consistently ranked low (use of e-cigarettes for smoking cessation, weight management to improve chronic obstructive pulmonary disease symptoms and handwashing to reduce infections). Limitations: Despite attempts to maximise inclusivity and diversity, stakeholders were mainly limited geographically to the centres where researchers were based, potentially limiting generalisability of views across the countries. Facilitator styles varied and may have influenced some of the discussions and potentially the ranking. Conclusions: Despite some limitations, we demonstrated the feasibility and acceptability of the rapid research prioritisation approach stakeholder analysis for identifying locally relevant research priorities in low- and middle-income country settings. Future work: Further validation is needed for aspects of the process. We have identified some useful lessons from our evaluation of the process, to facilitate future use of this approach. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Global Health Research programme as award number 16/137/95.

1 December 2024 in Global Health Research
Verified
Journal Article
Open access
ADAlexander D’eLia
Alexander D’eLia
RJRachel Jordan
Rachel Jordan
KCK.K. Cheng
K.K. Cheng
CCChunhua Chi
Chunhua Chi
JCJaime Correia-De-Sousa
Jaime Correia-De-Sousa
PAPeymane Adab
Peymane Adab
Background: Chronic obstructive pulmonary disease is one of the world’s leading causes of morbidity and mortality, with many low- and middle-income countries still experiencing an increase. Effective management requires a strong primary healthcare system, to prevent, diagnose in a timely way, and manage prevalent disease for a long period of time through to end of life, but this is inadequate in many middle-income countries. The Breathe Well programme was a multinational collaboration between the University of Birmingham, United Kingdom, and partner institutions in four middle-income countries: Brazil, China, Georgia and North Macedonia. This review, conducted at the start of the programme, aimed to set the context for our research programme and future research, health care and policy needs by describing these four national health systems, risk factors, current burden and management of chronic obstructive pulmonary disease patients. Design and methods: A descriptive review based on publicly available data identified from MEDLINE, national and international websites, supplemented by local expert opinion. For each of the included middle-income countries, we present and discuss the ability of the healthcare systems to effectively diagnose and manage chronic obstructive pulmonary disease, the barriers and limitations, including history of the healthcare system, organisation and governance, financing and medicines. The health and health care of chronic obstructive pulmonary disease patients are further illustrated by a hypothetical patient case developed with local clinical experts. Results: While the sizes and features of the populations differ, the number of doctors tends to be low across most countries, the number of smokers high, the out-of-pocket expenses also high and the provision of diagnosis and management for chronic obstructive pulmonary disease in primary care suboptimal. Primary prevention including smoking cessation is insufficient across the participating countries. Cost and availability of care and medications are common barriers to effective chronic obstructive pulmonary disease management. Limitations: This study is not a comprehensive systematic review. It provides a useful broad description of the subject, but we did not seek to produce detailed accounts. Discussion: While there is vast diversity in settings and context, some challenges appeared to be shared: a lack of human and material resources in the primary care systems with an apparent power imbalance between primary and secondary care, pushing care burden to secondary care and potentially worsening geographic and economic health inequities. High cost (relative to average earnings) and low accessibility of long-term medications lead to high out-of-pocket expenditure, affecting quality and equity. There is generally suboptimal primary prevention with high smoking rates and high levels of air pollution. Improvement of prevention, diagnosis and management of chronic obstructive pulmonary disease via stronger primary care could help reduce health inequalities. Future work: This study provided useful context for prioritising research questions within the Breathe Well programme and beyond. Research recommendations included assessment of resource-effective methods for primary prevention, screening and community-led management of chronic obstructive pulmonary disease cases, as well as mapping the educational needs of primary care staff which were then prioritised by local stakeholders including patients, clinicians, healthcare managers and policy-makers. It will be essential to update information on local context at regular intervals to ensure currency of research plans. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Global Health Research programme as award number 16/137/95.